Filing Details
- Accession Number:
- 0001127602-21-011174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-17 18:27:12
- Reporting Period:
- 2021-03-15
- Accepted Time:
- 2021-03-17 18:27:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1705850 | E Joseph Gilliam | C/O Glaukos Corporation 229 Avenida Fabricante San Clemente CA 92672 | Cfo, Svp Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-15 | 5,000 | $39.10 | 47,802 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-15 | 5,000 | $87.88 | 42,802 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-15 | 5,000 | $0.00 | 5,000 | $39.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,466 | 2030-03-12 | No | 4 | M | Direct |
Footnotes
- Includes 21,107 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
- These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.